Opko Health reported Q1 2025 revenue of $150.0M (-13.7% YoY), missed analyst consensus of $165.7M by $15.7M. Diluted EPS came in at $-0.10 (+16.7% YoY), missed the $-0.06 consensus by $0.04.
Trailing eight quarters through Q1 2025
Common questions about Opko Health's Q1 2025 earnings report.
Opko Health (OPK) reported Q1 2025 earnings on April 30, 2025 after market close.
Opko Health reported revenue of $150.0M and diluted EPS of $-0.10 for Q1 2025.
Revenue missed the consensus estimate of $165.7M by $15.7M. EPS missed the consensus estimate of $-0.06 by $0.04.
Compared to the same quarter a year prior, revenue declined 13.7% from $173.7M a year earlier and diluted EPS grew 16.7% from $-0.12.
You can read the 10-Q periodic report (0001437749-25-014086) directly on SEC EDGAR. The filing index links above go to sec.gov.